CMCSA three-lens brief
Evidence-based stock research on CMCSA. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Price down 12.90% in the last session — a material single-day move. · Underperforming SPY by 15.8pp over 30 days.
- Price down 12.90% in the last session — a material single-day move.
- Underperforming SPY by 15.8pp over 30 days.
- P/E of 5.4 — trading at a value multiple.
- Analyst mean target $32.73 — 19% above current (22 analysts).
- Debt-to-equity of 106.9 — balance-sheet-heavy.
CMCSA closed at $27.56 (-12.90%) as of 2026-04-25. Market cap: $98.45B. P/E (trailing) 5.4. Positives: p/E of 5.4 — trading at a value multiple.; analyst mean target $32.73 — 19% above current (22 analysts).. Concerns: price down 12.90% in the last session — a material single-day move.; underperforming SPY by 15.8pp over 30 days.. Last quarter: Revenue $31.46B, net income $2.17B, free cash flow $4.01B.
Why three lenses on CMCSA, not one.
A single reasoning model has blind spots it doesn’t know about. We examine CMCSAacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/CMCSA" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath CMCSA brief"></iframe>